150 related articles for article (PubMed ID: 24754006)
1. Testosterone replacement attenuates haloperidol-induced catalepsy in male rats.
Majidi Zolbanin N; Zolali E; Mohajjel Nayebi A
Adv Pharm Bull; 2014; 4(3):237-41. PubMed ID: 24754006
[TBL] [Abstract][Full Text] [Related]
2. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
3. Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
Moo-Puc RE; Góngora-Alfaro JL; Alvarez-Cervera FJ; Pineda JC; Arankowsky-Sandoval G; Heredia-López F
Neuropharmacology; 2003 Sep; 45(4):493-503. PubMed ID: 12907310
[TBL] [Abstract][Full Text] [Related]
4. Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
Kleven MS; Assié MB; Cosi C; Barret-Grévoz C; Newman-Tancredi A
Psychopharmacology (Berl); 2005 Feb; 177(4):373-80. PubMed ID: 15448976
[TBL] [Abstract][Full Text] [Related]
5. Effects of Immediate Aversive Stimulation on Haloperidol-Induced Catalepsy in Rats.
Waku I; Reimer AE; de Oliveira AR
Front Behav Neurosci; 2022; 16():867180. PubMed ID: 35481243
[TBL] [Abstract][Full Text] [Related]
6. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Verma A; Kulkarni SK
Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
Banasikowski TJ; Beninger RJ
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
[TBL] [Abstract][Full Text] [Related]
8. Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2013; 3(1):203-6. PubMed ID: 24312836
[TBL] [Abstract][Full Text] [Related]
9. Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson's Disease.
de Moraes Santos Corrêa É; Christofoletti G; de Souza AS
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791229
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Banasikowski TJ; Beninger RJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
[TBL] [Abstract][Full Text] [Related]
11. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
Invernizzi RW; Garavaglia C; Samanin R
Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
Góngora-Alfaro JL; Moo-Puc RE; Villanueva-Toledo JR; Alvarez-Cervera FJ; Bata-García JL; Heredia-López FJ; Pineda JC
Neurosci Lett; 2009 Oct; 463(3):210-4. PubMed ID: 19654037
[TBL] [Abstract][Full Text] [Related]
13. Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.
Abdel-Salam OM; El-Sayed El-Shamarka M; Salem NA; El-Din M Gaafar A
EXCLI J; 2012; 11():45-58. PubMed ID: 27366134
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat.
Ionov ID; Severtsev NN
Pharmacol Biochem Behav; 2012 Dec; 103(2):295-8. PubMed ID: 23036801
[TBL] [Abstract][Full Text] [Related]
15. Cyclosomatostatin- and haloperidol-induced catalepsy in Wistar rats: Differential responsiveness to sleep deprivation.
Ionov ID; Pushinskaya II; Gorev NP; Frenkel DD
Neurosci Lett; 2018 Sep; 684():72-77. PubMed ID: 29990558
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
Prinssen EP; Colpaert FC; Koek W
Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
[TBL] [Abstract][Full Text] [Related]
17. Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
Mehta AK; Ticku MK
Life Sci; 1990; 46(1):37-42. PubMed ID: 2153885
[TBL] [Abstract][Full Text] [Related]
18. Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice.
Nair V; Arjuman A; Gopalakrishna HN; Nandini M
Phytother Res; 2008 Feb; 22(2):243-6. PubMed ID: 17886228
[TBL] [Abstract][Full Text] [Related]
19. The effect of chronic administration of buspirone on 6-hydroxydopamine-induced catalepsy in rats.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2012; 2(1):127-31. PubMed ID: 24312782
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
